Demetra Ashley, the former acting assistant administrator of the DEA, has previously testified before Congress on the government’s efforts to stop the nationwide opioid crisis.
Purdue Pharma is one of the opioid companies being sued by more than 1,600 cities and counties for misleading physicians and patients about the risks of using opioid painkillers long term. Many of the lawsuits have been consolidated into one case in Cleveland.
Purdue Pharma denies the allegations.
Ms. Ashley spent three decades at the DEA specializing in preventing the diversion of drugs like OxyContin.
“I have been consulting for members of the industry, and I began my consulting business in June 2018 after I retired,” Ms. Ashley told NBC News.
Purdue Pharma declined NBC News‘ request for comment.
More articles on pharmacy:
Harvard gets $100M infusion for drug research from hedge fund
Purdue Pharma CEO: Bankruptcy is ‘an option’ amid lawsuits
Intermountain CEO Dr. Marc Harrison: How Civica Rx will disrupt the drug industry
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
